Company profile for Chongqing Pharmaceutical Research Institute Co Ltd

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Chongqing Pharmaceutical Research Institute Co., Ltd. (CPRI) is an R&D-based & client-oriented enterprise engaged in: Pharmaceutical R&D Early stage process development cGMP manufacturing of APIs & advanced intermediates Founded in 1950s, formerly known as the state-owned Chongqing Pharmaceutical Research Institute, CPRI was one of the pioneers involved in drug R&D and cGMP-compliant API manufacturing in China. In 2001, CP...
Chongqing Pharmaceutical Research Institute Co., Ltd. (CPRI) is an R&D-based & client-oriented enterprise engaged in: Pharmaceutical R&D Early stage process development cGMP manufacturing of APIs & advanced intermediates Founded in 1950s, formerly known as the state-owned Chongqing Pharmaceutical Research Institute, CPRI was one of the pioneers involved in drug R&D and cGMP-compliant API manufacturing in China. In 2001, CPRI became a subsidiary of FOSUN Pharmaceutical (Group), Co, Ltd, which is a leading pharmaceutical company in China.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Tushan 565, Nanan District Chongqing, 400061P.R.China
Telephone
Telephone
86-23-62504026
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.hc-sc.gc.ca/dhp-mps/pubs/compli-conform/tracker-suivi-eng.php

HEALTH CANADA
25 Mar 2017

https://www.pharmacompass.com/pdf/news/chongqing-pharma-research-institute-receives-fda-warning-letter-1488363786.pdf

FDA
01 Mar 2017
Fosun-owned API maker Chongqing criticized by US FDA
Fosun-owned API maker Chongqing criticized by US FDA

01 Mar 2017

// Gareth MacDonald+ IN PHARMATECHNOLOGIST

http://www.in-pharmatechnologist.com/Ingredients/Fosun-owned-API-maker-Chongqing-criticized-by-US-FDA

Gareth MacDonald+ IN PHARMATECHNOLOGIST
01 Mar 2017

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Chongqing Pharmaceutical Research Institute Co Ltd and get a quotation

Chongqing Pharmaceutical Research Institute Co Ltd is a supplier offers 7 products (APIs, Excipients or Intermediates).

Find a price of Pemetrexed Disodium bulk with JDMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

Find a price of Canagliflozin bulk with DMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

Find a price of Hydrotalcite Bp bulk with DMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

Find a price of Iron Sucrose bulk with DMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

Find a price of Abiraterone Acetate bulk offered by Chongqing Pharmaceutical Research Institute Co Ltd

Find a price of Amrinone bulk offered by Chongqing Pharmaceutical Research Institute Co Ltd

Find a price of Carfilzomib bulk offered by Chongqing Pharmaceutical Research Institute Co Ltd

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty